Innokas Medical, with expertise dedicated to medical devices and software, and Biocodex PhaMe, providing pharmaceutical consultant services, have agreed on a strategic partnership. Through this collaboration and joint service offering, Innokas Medical and Biocodex PhaMe seek synergy effects and added value for companies developing drug-device combination products to the market.
“In addition to quality and regulatory consultancy related to pharmaceuticals, our customers usually seek for a knowledgeable co-creation partner for design and development of a medical device or software. Through the collaboration between Biocodex PhaMe and Innokas Medical, we’re therefore able to serve our customers with more a comprehensive service offering in future”, tells Jonas Hinkkanen, working as Head of Regulatory Affairs, Nordics and the Baltic, at Biocodex PhaMe. ”We wanted to meet the growing need of companies developing drug-device combination products by putting more focus on extending our joint services available for them”, he continues.
Biocodex Pharmaceutical and Medical Service Unit (PhaMe) provides a comprehensive range of pharmaceutical and medical services like auditing, regulatory and pharmacovigilance services, and is a part of multinational pharmaceutical company Biocodex Group.
Here you can find more of our latest news and insights in this category.
Here you can find more of our latest news, tips and insights.
Here you can find more of our latest news and insights.
Here you can find more of our insights, news and tips.
Here you can find more of our insights, news and tips.